SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending after reporting a massive earnings beat and an expanded $14 billion share buyback, though the stock has faced downward pressure due to investor concerns that its forward guidance fell short of aggressive expectations. The community is sharply divided, with bulls pointing to record-breaking margins and structural AI-driven demand, while bears argue the cyclical nature of memory chips and recent valuation surges make the stock vulnerable to profit-taking.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following strong Q2 results that featured record revenue and a full-year guidance increase, sparking significant community debate over the potential for a short squeeze. Investors are closely monitoring the stock's high short interest and the successful adoption of its OASYS platform, while discussions weigh the company's growth momentum against persistent concerns regarding its path to profitability.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is facing extreme market volatility following a mixed earnings report where a slight revenue miss and cautious forward guidance triggered a sharp sell-off. While the community is debating whether the stock is a severely oversold opportunity or a sign of slowing growth in the ad-tech sector, many investors are focused on the company's strong margins, share buyback program, and the resolution of the SEC investigation as catalysts for a potential recovery.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to the final regulatory approval of its acquisition of SkyWater Technology, a strategic move aimed at vertically integrating its operations and securing a domestic semiconductor supply chain. While the stock has faced volatility, the community is heavily focused on how this manufacturing control will accelerate the company's quantum roadmap and influence upcoming earnings guidance.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is trending as investors weigh its solid Q2 earnings performance and growing backlog against sector-wide volatility and broader concerns about space infrastructure valuations. The community is actively discussing the stock's potential for a short squeeze, its long-term defense-tech thesis, and the impact of institutional accumulation ahead of upcoming milestones.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is facing significant selling pressure as investors react to disappointing earnings, margin contraction, and concerns regarding project execution timelines. While the community remains divided, many are focused on the long-term potential of its massive $6.4 billion backlog and its role in the expanding AI data center infrastructure.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending as investors debate whether recent volatility and heavy short interest signal a potential short squeeze or an overvalued asset facing long-term competitive threats. Community discourse remains sharply divided between bulls highlighting strong revenue growth and AI integration and bears focusing on institutional insider selling and valuation concerns.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares are facing significant downward pressure as investors rotate out of semiconductor and memory plays, despite the company's recent earnings beat and sustained demand for AI-related storage infrastructure. Market participants are actively debating whether this sell-off is a rational repricing due to valuation concerns and macro fears regarding international competition, or an overextended reaction driven by algo-heavy institutional selling.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors focus on the upcoming Phase 2 clinical readout for ABCL635, a potential blockbuster treatment for vasomotor symptoms. The community is actively debating the company's valuation, recent pharmaceutical partnerships with firms like Jazz and Vertex, and its shift from a discovery service provider to a developer of proprietary drug assets.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the community closely monitors the company's recent publication of pediatric safety data, which is widely viewed as a strategic move to bolster its case for pending European regulatory approval. Investors are actively debating the significance of this data alongside the company's strong cash position and the potential for a favorable shift in market valuation as it awaits the outcome of the European Medicines Agency's review process.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Possible Generic Drug Tariffs and 2 Microcaps

Generic drug tariffs could impact ELTP and CPIX.

ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?

Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks more compelling now? Let's dive in.

Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 Earnings

ELTP delivers record fiscal 2026 results, with stronger profits, improved cash and pipeline progress supporting its expanding generics platform.

The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies

GE, SHEL and MCK lead Zacks picks, driven by strong demand, cash flow growth and strategic expansion despite cost and market risks.

Top Stock Reports for GE Aerospace, Shell & McKesson

GE Aerospace gains on strong engine demand and defense tailwinds, while Shell and McKesson navigate mixed performance and strategic shifts.

Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump

ELTP reports surging revenue and profit in third-quarter fiscal 2026, but margin pressure and M&A ambitions steal the spotlight.

ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance

Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.

The Zacks Analyst Blog Highlights Berkshire Hathaway, Toyota Motor, McDonald's, Elite Pharmaceuticals and BK Technologies

Zacks highlights Berkshire Hathaway, Toyota, McDonald's, Elite Pharma and BK Technologies as diverse plays with unique growth catalysts and risks.

Top Analyst Reports for Berkshire Hathaway, Toyota Motor & McDonald's

Analysts spotlight Berkshire, Toyota and McDonald's, highlighting growth drivers, risks and market performance in new research reports.

ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth

Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.

Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the following segments: Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Elite Pharmaceuticals, Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info